Sonazoid™

DRUG2 trials

Sponsors

GE Healthcare

Conditions

HealthyLiver Lesions

Phase 1

A Study to Evaluate Pharmacokinetics of Sonazoid™ Following Intravenous Bolus Injection in Healthy Volunteers

CompletedNCT03340870

GE HealthcareHealthy

Start: 2014-10-20End: 2014-11-20Updated: 2017-11-14

Phase 3

An Efficacy and Safety Study of Sonazoid™ and SonoVue® in Participants With Focal Liver Lesions, Undergoing Pre- and Post-Contrast Ultrasound Imaging

CompletedNCT03335566

GE HealthcareLiver Lesions

Start: 2014-05-11End: 2015-04-09Updated: 2018-10-31